WBDE: Subsidiary obtains invention patents for the prevention and treatment of Alzheimer's disease and skin photoaging

Zhitong
2025.07.14 08:06

WBDE announced that its wholly-owned subsidiary, WBDE Pharmaceutical Group Co., Ltd., recently obtained the "Invention Patent Certificate" from the National Intellectual Property Administration, with the invention titled "A Composition, Preparation and Its Application for the Prevention and Treatment of Alzheimer's Disease and Skin Photoaging." This patent innovatively develops a Class 1 new drug compound composition of "Ginseng-Ginkgo Leaf-Millepertuis," characterized by high safety, low dosage, simple drug composition, and better efficacy. With the integrated regulatory advantages of multi-components, multi-targets, and multi-pathways, it forms an innovative therapy to intervene in the pathological network of Alzheimer's disease, providing patients with treatment options superior to existing single-agent pharmaceuticals

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer